The private equity market will likely drive IPO volumes higher than 2024, but the strength of the PE market could cap the ...

Moreover, five of the top 10 IPO candidates the report highlights are in tech-related sectors that were battered in the DeepSeek downturn, like software-as-a-service, artificial intelligence and ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...